Immunological Data Discovery Index
Advanced Search
identifier: SDY33
description:
A prospective longitudinal study comparing renal transplant patients with controls to determine the biological mechanisms that underlie the immunosuppressed state associated with immunosuppressive regimens after transplantation.
aggregation:
instance of dataset
refinement:
2 - Complete set of descriptive data and results, as ascertained by ImmPort.
availability:
available with registration
primaryPublications: 21220454
18449194
19247287
isAbout:
To determine the effects of chronic immunosuppressive therapies on adaptive immunity: Effects on the phenotype and functional properties of T cell and B cell subsets and antigen-specific T cells. To determine the effects of chronic immunosuppressive therapies on innate immunity, dendritic cell phenotype, function and TLR signaling. To define the transcriptional signatures associated with specific immunosuppressive regimens.
clinical trial:
study category: Vaccine Response
study type: Observational
subject species: Homo sapiens
biosample type: Cell
Other
RNA
subject gender: Both
assay type: DNA microarray
ELISPOT
Flow Cytometry
HLA Typing
name:
Assessment of vaccine response in chronically immunosuppressed renal transplant patients.
fullName:
Christian Larsen
affiliations:
Emory Transplant Center
roles:
principal investigator
name:
Impact of immunosuppressive regimens on protective immunity in renal transplant recipients
size:
116
name:
Protective Immunity in Transplant Recipients
output:
HLA genotyping of enrolled subjects. FCM experiment to measure frequency and phenotypic profile of B and T cell subsets in chronically immunosuppressed patients. CD107A degranulation assay to assess numbers and function of antigen-specific memory T cells in chronic immunosuppression. CFSE proliferation assay to assess numbers and function of antigen-specific memory T cells in chronic immunosuppression. ELISPOT assay to assess memory B cell function in renal transplant patients with tacrolimus and sirolimus treatment. ELISA serum antibody titers to assess memory B cell function in renal transplant patients with tacrolimus and sirolimus treatment. Effects of chronic immunosuppression on dendritic cell function. Microarray experiment to define the transcriptional signatures associated with specific immunosuppressive regimens. Viral monitoring by PCR.
studyGroups:
De novo transplant, No Induction, Tacrolimus Maintenance: De novo Renal Transplant Patients, No Induction Therapy, Tacrolimus Maintenance
De novo transplant, No Induction, Sirolimus Maintenance: De novo Renal Transplant Patients, No Induction Therapy, Sirolimus Maintenance
De novo transplant, With Induction, Tacrolimus Maintenance: De novo Renal Transplant Patients, With Induction Therapy, Tacrolimus Maintenance
De novo transplant, With Induction, Sirolimus Maintenance: De novo Renal Transplant Patients, With Induction Therapy, Sirolimus Maintenance
De novo transplant, With Induction, Efalizumab Maintenance: De novo Renal Transplant Patients, With Induction, Efalizumab Maintenance
Donor (surgical) Controls: Healthy donor (surgical) controls
Healthy Controls: Healthy controls
description:
A prospective longitudinal study to determine biological mechanisms that underlie the immunosuppressed state associated with immunosuppressive regimens after renal transplantation.
identifier:
10.21430/M3TJ6DJLEY
name:
ImmPort
identifier:
SCR:012804
homePage: http://www.immport.org

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.